Inventor · disambiguated record
Stefan Mccarver
Also filed as: MCCARVER STEFAN · MCCARVER STEFAN J
5 granted patents·6 pending applications·6 citations·filing 2021–2024
71Inventor score
Files withJANSSEN PHARMACEUTICA NV11
Top patents by PatentIndex Score
11 records- 0192US11691979B2Imidazopyridazines as modulators of IL-17JANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jul 4, 2023·3 cites·47 claims
- 0291US11702422B2Imidazopyridazines as modulators of IL-17JANSSEN PHARMACEUTICA NV·Filed 2022·Granted Jul 18, 2023·2 cites·24 claims
- 0388US12024524B2Imidazopyridazines as modulators of IL-17JANSSEN PHARMACEUTICA NV·Filed 2023·Granted Jul 2, 2024·1 cites·20 claims
- 0473US12215111B2Imidazopyridazine IL-17 inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Feb 4, 2025·0 cites·24 claims
- 0570US2025206744A1Imidazopyridazine il-17 inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0666US12173007B2Imidazopyridazine IL-17 inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Dec 24, 2024·0 cites·33 claims
- 0763US2025109137A1Imidazopyridazine il-17 inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0858US2024376085A1Benzimidazoles as modulators of il-17JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0958US2025122181A1Benzimidazoles as modulators of il-17JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1055US2023339900A1Casein kinase 1 delta modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1153US2023339970A1Casein kinase 1 delta modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefan Mccarver files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →